Navigation Links
Functional Regeneration of the Macula with Autologous Stem Cells
Date:7/30/2013

QUERETARO, Mexico, July 30, 2013 /PRNewswire/ -- The company CELLMAK is dedicated to biomedical research in regenerative cellular medicine and tissue engineering with a group of scientists led by Biomedical Researcher Mario Camacho.

Five years ago we began our work on clinical research protocols for the functional Regeneration of the Retina, working with cases of Age-related Macular, Glaucoma and Optic Nerve Atrophy, using autologous stem cells from bone marrow with excellent results.  In other countries, at present they are only in the initial clinical research protocols for these ailments. 

We do not commercialize treatments, but since we do not have support from the government or large companies, patients, who are evaluated by the ophthalmologists we work with as viable candidates for our protocols, pay out of their own pockets for the inputs and medical fees involved. 

We Mexicans are proud to be competing with research groups from all over the world, many of them endowed with multi-million dollar support from their governments or major corporations.  

CELLMAK has distinguished itself as the first company in Latin America successfully to introduce Cellular Facial Rejuvenation to the market, using the patient's own fatty tissue cells, and without surgery! 

We are located in the city of Queretaro, one of the safest and most beautiful cities in Mexico, where people come to see us from all over the world. 

Our protocols depend on COFEPRIS, Mexico's regulatory agency for health matters.  At present the FDA has no role whatsoever in regulating us.  

CELLMAK is a company founded by Biomedical Researcher Mario Camacho and his wife, Karyna Camacho, who have worked indefatigably to create the technology and appropriate standards for the application of autologous stem cells (that is, using the patient's own stem cells) for Mexico and the world.

At CELLMAK we work to improve the quality of people's lives, and are putting Mexico in first place, competing at the global level in the generation of new technology. 

Make an appointment now and find out how you can participate in our clinical research protocols.

Mario Camacho is a Biomedical Researcher engaged in comprehensive handling of autologous stem cells, and he works with medical specialists who clinically evaluate viable candidates and deal directly with the patients.

Contact information:

https://www.facebook.com/Cellmak 
e-mail: celulasmadre1@aol.com 
Phone: (52) 442 2200546 and 442 2452997
also soon at: www.cellmak.com


'/>"/>
SOURCE CELLMAK
Copyright©2012 PR Newswire.
All rights reserved

Related biology technology :

1. Veeva CRM Adds New Survey Functionality to Deepen Customer Understanding and Drive More Relevant Interactions
2. Pusan National University Announces Science Translational Medicine Publication Highlighting Landmark Demonstration of Functional Anti-Cancer Antibody Induction in Patients Following JX-594 Treatment
3. Preliminary Research, Led By Dr. Vincent Giampapa, Finds Aged Adult Stem Cells Can Be Functionally Reprogrammed To Act Like Younger Cells
4. Researchers build functional ovarian tissue in lab
5. New injectable hydrogel encourages regeneration and improves functionality after a heart attack
6. ALCAT Pioneer, Roger Deutsch, to Address "Food Allergies and Intolerances" at the Institute of Functional Medicine Conference in Tampa, February 8-10
7. Neuralstem Cells Induce Significant Functional Improvement In Permanent Rat Spinal Cord Injury, Cell Study Reports
8. New structural information on functionalization of gold nanoparticles
9. Baylor College of Medicine and Gradalis Enter Collaboration Agreement to Utilize Gradalis Bifunctional shRNA Platform in Translational Medicine Research
10. RURO Adds Critical Level Monitoring Functionality to its Inventory Management Software FreezerPro.
11. Seahorse Launches Reagent to Make Functional Fatty Acid Oxidation (FAO) Assays Easy
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/4/2016)... Missouri (PRWEB) , ... May 04, 2016 , ... PBI-Gordon ... Professional and Agricultural Sales. , Doug began his career at PBI-Gordon in February ... served in a wide variety of roles, ranging from customer service to national product ...
(Date:5/3/2016)... India , May 3, 2016 /PRNewswire/ ... (DNA Chip (Genomics, Drug Discovery, Gene Expression) ... End user (Academics Institutes, Diagnostics Centers), Fabrication ... published by MarketsandMarkets, the market is expected ... from USD 7.63 Billion in 2015, growing ...
(Date:5/3/2016)... ... 03, 2016 , ... In a list published by the Boston Business Journal, ... private companies; a small percentage of the state's 615,000+ small businesses. The list examined ... in revenue from 2012 to 2015. , As this award comes on ...
(Date:5/3/2016)... ... May 03, 2016 , ... Flagship Biosciences, the leader ... to its Board of Directors. Dr. Gillett recently retired from Charles River Laboratories ... and Chief Scientific Officer. A board-certified veterinary pathologist, Dr. Gillett joined Charles River ...
Breaking Biology Technology:
(Date:3/18/2016)... --> --> ... & Unmanned Vehicles, Physical infrastructure and Perimeter Surveillance & Detection ... border security market and the continuing migration crisis in the ... has led visiongain to publish this unique report, ... defence & security companies in the border security ...
(Date:3/15/2016)... 15, 2016 Yissum Research Development Company ... company of the Hebrew University, announced today the formation ... technology of various human biological indicators. Neteera Technologies has ... from private investors. ... detection of electromagnetic emissions from sweat ducts, enables reliable ...
(Date:3/11/2016)... , March 11, 2016 http://www.apimages.com ) - ... reference: Picture is available at AP Images ( http://www.apimages.com ) - ... will be used to produce the new refugee identity cards. DERMALOG ... innovations, at CeBIT in Hanover next week.   ... DERMALOG will be used to produce the new refugee identity cards. ...
Breaking Biology News(10 mins):